Related content

Improving upon the promise of targeted therapy of human malignancy: chronic myeloid leukemia as a paradigm

By Shah Neil  

Cancer Chemotherapy and Pharmacology, Vol. 58, Iss. 7, 2006-11 ,pp. : 49-53

Springer Publishing Company

Access to resources Recommend Favorite

Current status of therapy for chronic myeloid leukemia: a review of drug development

By Padmanabhan Swami   Ravella Saritha   Curiel Tyler   Giles Francis  

Future Oncology, Vol. 4, Iss. 3, 2008-06 ,pp. : 359-377

Future Medicine

Access to resources Recommend Favorite

Basic science going clinical: molecularly targeted therapy of chronic myelogenous leukemia

By Deininger Michael  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 2, 2004-02 ,pp. : 59-72

Springer Publishing Company

Access to resources Recommend Favorite

Advances in the biology and therapy of chronic myeloid leukemia: proceedings from the 6th Post-ASH International Chronic Myeloid Leukemia and Myeloproliferative Neoplasms Workshop

By van Etten Richard A.  

Leukemia and Lymphoma, Vol. 54, Iss. 6, 2013-06 ,pp. : 1151-1158

Informa Healthcare

Access to resources Recommend Favorite

Emerging Targeted Therapies for Pediatric Acute Myeloid Leukemia

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 6, Iss. 3, 2011-09 ,pp. : 354-366

Bentham Science Publishers

Access to resources Recommend Favorite